Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A novel p16INK4A transcript

L Mao1, A Merlo, G Bedi

  • 1Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205-2196, USA.

Cancer Research
|July 15, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimizing particle transport for enhanced confinement in quasi-isodynamic stellarators.

Physical review. E·2026
Same author

TBCRC 035: randomized phase II pharmacodynamic study of standard and reduced-dose palbociclib with endocrine therapy in hormone receptor (HR)-positive previously treated metastatic breast cancer.

ESMO open·2026
Same author

A phase I/II study of the safety and efficacy of telaglenastat (CB-839) in combination with nivolumab in patients with metastatic melanoma, renal cell carcinoma, and non-small-cell lung cancer.

ESMO open·2025
Same author

Final results from the phase Ia/Ib study of the novel bromodomain and extra-terminal domain inhibitor, BI 894999, in patients with advanced solid tumors or diffuse large B-cell lymphoma.

ESMO open·2025
Same author

Dopa responsive dystonia due to a GCH1 gene variant mimicking hereditary spastic paraparesis.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2025
Same author

Alcohol Consumption During the COVID-19 Pandemic: A Critical Review.

Human psychopharmacology·2025
Same journal

CDK2 Inhibition Exerts RB-Independent Antitumor Activity in CDK4/6 Inhibitor-Resistant HR+/HER2- Breast Cancer.

Cancer research·2026
Same journal

A Clinically Integrated Pediatric Patient-Derived Xenograft Program Enables Evaluation of Cohort and Patient-Specific Biology and Therapeutic Strategies.

Cancer research·2026
Same journal

Editor's Note: Heterodimerization of Insulin-like Growth Factor Receptor/Epidermal Growth Factor Receptor and Induction of Survivin Expression Counteract the Antitumor Action of Erlotinib.

Cancer research·2026
Same journal

Editor's Note: Deguelin Analogue SH-1242 Inhibits Hsp90 Activity and Exerts Potent Anticancer Efficacy with Limited Neurotoxicity.

Cancer research·2026
Same journal

Retraction: Two Functional Epitopes of Pigment Epithelial-Derived Factor Block Angiogenesis and Induce Differentiation in Prostate Cancer.

Cancer research·2026
Same journal

Editor's Note: Chronic Stress Facilitates Lung Tumorigenesis by Promoting Exocytosis of IGF2 in Lung Epithelial Cells.

Cancer research·2026
See all related articles

Researchers discovered a novel alternative p16 transcript originating from exon 1 beta. This finding sheds light on the complex regulation of cell cycle genes, particularly in neoplasms where p16 is often affected.

Area of Science:

  • Molecular Biology
  • Cancer Genetics

Background:

  • p16INK4A and p15INK4B are key inhibitors of cyclin-dependent kinase complexes.
  • These genes are located on chromosome 9p21, a region frequently altered in various cancers.
  • Methylation of the p16 gene's 5' CpG island can block its full-length transcript in neoplasms.

Purpose of the Study:

  • To investigate the presence of an alternative promoter or initiation site for p16.
  • To identify the source of a truncated p16 transcript observed in methylated cell lines.

Main Methods:

  • Analysis of p16 transcripts in both methylated and unmethylated cell lines.
  • Identification of novel sequences, including exon 1 beta, involved in p16 gene expression.

Main Results:

Related Experiment Videos

  • An abundant alternative p16 transcript was identified.
  • This transcript originates from a novel sequence, termed exon 1 beta.
  • The alternative transcript is present in both methylated and unmethylated cell lines.

Conclusions:

  • A novel alternative promoter or initiation site for p16 has been identified.
  • Exon 1 beta is a key component of this alternative transcript, suggesting a role in p16 regulation.
  • This discovery contributes to understanding the complex regulation of cell cycle genes like p16 in cancer.